Sugi Predict

Sugi Predict / Compounds / SCHEMBL7182930

SCHEMBL7182930

SCHEMBL7182930

COc1c(Cl)cc(Br)c(OC)c1C(=O)P(=O)(C(=O)c1c(C)cccc1C)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.43
▸ TAS1R3 Q7RTX0 4/20 0.41
▸ TAS1R1 Q7RTX1 4/20 0.41
▸ TAS1R2 Q8TE23 4/20 0.41
▸ KDM4E B2RXH2 4/20 0.37
▸ MAPT P10636 3/20 0.37
▸ PKM P14618 1/20 0.37
▸ ALDH1A1 P00352 6/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35
▸ LMNA P02545 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7180971 0.96 POLB (0.41) POLBTAS1R3TAS1R1TAS1R2KDM4E
SCHEMBL7175785 0.92 POLB (0.42) POLBTAS1R3TAS1R1TAS1R2KDM4E
SCHEMBL7182765 0.92 TAS1R3 (0.45) TAS1R3TAS1R1TAS1R2KDM4EMAPT
SCHEMBL7187549 0.91 POLB (0.42) POLBTAS1R3TAS1R1TAS1R2KDM4E
SCHEMBL7189138 0.89 POLB (0.40) POLBTAS1R3TAS1R1TAS1R2KDM4E
SCHEMBL7175863 0.89 POLB (0.40) POLBKDM4EMAPTALDH1A1HSD17B10
SCHEMBL7190080 0.88 POLB (0.41) POLBTAS1R3TAS1R1TAS1R2KDM4E
SCHEMBL7185490 0.87 LMNA (0.41) KDM4EMAPTPKMALDH1A1SMN1; SMN2
SCHEMBL7189336 0.87 TAS1R3 (0.43) TAS1R3TAS1R1TAS1R2KDM4EMAPT
SCHEMBL7182058 0.87 TOP1 (0.39) POLBTAS1R3TAS1R1TAS1R2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 — — US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 — — US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 — — US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 POLB 2322/4885TAS1R3 2990/4885TAS1R1 3374/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 POLB 2993/4885TAS1R3 3176/4885TAS1R1 3927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.